PTSM: Pharmaceutical Technology Sourcing and Management-01-09-2013

Financing from initial public offerings and global mergers and acquisitions were down in 2012 and venture-capital funding stayed strong.

The quest to build critical mass and broaden capabilities has been a key factor in dealmaking.

As a new year begins, what may be on the horizon for 2013 for the biopharmaceutical/pharmaceutical companies and their suppliers? A look ahead into what issues are shaping the industry.

A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

GlaxoSmithKline partners with the mobile telecommunications company Vodafone to tackle common infectious diseases in Africa.